Literature DB >> 15575064

The fragility of the U.S. vaccine supply.

Frank A Sloan1, Stephen Berman, Sara Rosenbaum, Rosemary A Chalk, Robert B Giffin.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15575064     DOI： 10.1056/NEJMsb033394

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Balancing vaccine science and national policy objectives: lessons from the National Vaccine Injury Compensation Program Omnibus Autism Proceedings.

Authors:  Jennifer Keelan; Kumanan Wilson
Journal:  Am J Public Health       Date:  2011-09-22       Impact factor: 9.308

2.  Childhood immunization controversies: what are parents asking?

Authors:  Daniel R Bronfin
Journal:  Ochsner J       Date:  2008

3.  An analysis of the pediatric vaccine supply shortage problem.

Authors:  Sheldon H Jacobson; Edward C Sewell; Ruben A Proano
Journal:  Health Care Manag Sci       Date:  2006-11

Review 4.  Anthrax vaccine and public health policy.

Authors:  Martin Meyer Weiss; Peter D Weiss; Joseph B Weiss
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

5.  Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.

Authors:  Anna Bershteyn; Melissa C Hanson; Monica P Crespo; James J Moon; Adrienne V Li; Heikyung Suh; Darrell J Irvine
Journal:  J Control Release       Date:  2011-07-24       Impact factor: 9.776

6.  Factors associated with the pricing of childhood vaccines in the U.S. public sector.

Authors:  Weiwei Chen; Mark Messonnier; Fangjun Zhou
Journal:  Health Econ       Date:  2017-06-29       Impact factor: 3.046

7.  Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies.

Authors:  Ashaben Patel; Vineet Gupta; John Hickey; Nancy S Nightlinger; Richard S Rogers; Christine Siska; Sangeeta B Joshi; Michael S Seaman; David B Volkin; Bruce A Kerwin
Journal:  J Pharm Sci       Date:  2018-09-01       Impact factor: 3.534

8.  Size of clinical trials and Introductory prices of prophylactic vaccine series.

Authors:  Steven H Weinberg; Amy T Butchart; Matthew M Davis
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

Review 9.  Pandemic influenza threat and preparedness.

Authors:  Anthony S Fauci
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

Review 10.  Vaccine supply, demand, and policy: a primer.

Authors:  Jagannath M Muzumdar; Richard R Cline
Journal:  J Am Pharm Assoc (2003)       Date:  2009 Jul-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.